Documents
Application Sponsors
Marketing Status
Prescription | 001 |
Prescription | 002 |
Application Products
001 | CAPSULE;ORAL | 100MG | 2 | ROZLYTREK | ENTRECTINIB |
002 | CAPSULE;ORAL | 200MG | 2 | ROZLYTREK | ENTRECTINIB |
FDA Submissions
TYPE 9; Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval | ORIG | 1 | AP | 2019-08-15 | PRIORITY |
Submissions Property Types
TE Codes
001 | Prescription | TBD |
002 | Prescription | TBD |
CDER Filings
GENENTECH INC
cder:Array
(
[0] => Array
(
[ApplNo] => 212726
[companyName] => GENENTECH INC
[docInserts] => ["",""]
[products] => [{"drugName":"ROZLYTREK","activeIngredients":"ENTRECTINIB","strength":"100MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"TBD","rs":"No"},{"drugName":"ROZLYTREK","activeIngredients":"ENTRECTINIB","strength":"200MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"TBD","rs":"No"}]
[labels] => [{"actionDate":"08\/15\/2019","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/212726s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"08\/15\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"PRIORITY; Orphan","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/212726s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/212726Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2019\\\/212725Orig1s000,%20212726Orig1s000TOC.cfm\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2019-08-15
)
)